Lv4
454 积分 2024-07-02 加入
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
3小时前
已完结
Definition of diaphragmatic sleep disordered breathing and clinical meaning in Duchenne muscular dystrophy
4个月前
已完结
Risk factors for falls among boys under 18 years with muscular dystrophy
5个月前
已关闭
Timed function tests have withstood the test of time as clinically meaningful and responsive endpoints in duchenne muscular dystrophy
5个月前
已完结
Nutritional and Gastrointestinal Management of the Patient With Duchenne Muscular Dystrophy
5个月前
已完结
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
5个月前
已完结
A longitudinal study of creatine kinase and creatinine levels in Duchenne muscular dystrophy
6个月前
已完结
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
7个月前
已完结
10.1016/S0140-6736(17)32160-8
7个月前
已完结
皖公网安备34019202002308
